Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
Iezzi R, Pompili M, Rinninella E, Annicchiarico E, Garcovich M, Cerrito L, Ponziani F, De Gaetano A, Siciliano M, Basso M, Zocco MA, Rapaccini G, Posa A, Carchesio F, Biolato M, Giuliante F, Gasbarrini A, Manfredi R; HepatoCatt Study Group. Iezzi R, et al. Among authors: zocco ma. Eur Radiol. 2019 Mar;29(3):1285-1292. doi: 10.1007/s00330-018-5692-8. Epub 2018 Aug 31. Eur Radiol. 2019. PMID: 30171360
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.
Di Caro S, Ojetti V, Zocco MA, Cremonini F, Bartolozzi F, Candelli M, Lupascu A, Nista EC, Cammarota G, Gasbarrini A. Di Caro S, et al. Among authors: zocco ma. Aliment Pharmacol Ther. 2002 Mar;16(3):527-32. doi: 10.1046/j.1365-2036.2002.01165.x. Aliment Pharmacol Ther. 2002. PMID: 11876707 Free article. Clinical Trial.
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial.
Nista EC, Candelli M, Cremonini F, Cazzato IA, Di Caro S, Gabrielli M, Santarelli L, Zocco MA, Ojetti V, Carloni E, Cammarota G, Gasbarrini G, Gasbarrini A. Nista EC, et al. Among authors: zocco ma. Aliment Pharmacol Ther. 2003 Sep 15;18(6):627-33. doi: 10.1046/j.1365-2036.2003.01676.x. Aliment Pharmacol Ther. 2003. PMID: 12969089 Free article. Clinical Trial.
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate.
Ojetti V, Migneco A, Zocco MA, Nista EC, Gasbarrini G, Gasbarrini A. Ojetti V, et al. Among authors: zocco ma. J Intern Med. 2004 Jan;255(1):125-9. doi: 10.1046/j.0954-6820.2003.01239.x. J Intern Med. 2004. PMID: 14687248 Free article. Clinical Trial.
133 results